肾上皮样血管平滑肌脂肪瘤1例报告及文献复习

王曦龙; 王洋; 章俊; 出晓军; 王阳赟; 施国伟

肾上皮样血管平滑肌脂肪瘤1例报告及文献复习

- 复旦大学附属上海市第五人民医院泌尿外科(上海, 200240)

详细信息

通讯作者: 施国伟,E-mail:dr.sgw@126.com

中图分类号: R737.11

收稿日期: 2012-12-30

Renal epithelioid angiomyolipoma: a case report and literature review

- Department of Urology, Fifth People's Hospital of Shanghai, Fudan University, Shanghai, 200240, China

More Information

Corresponding author: SHI Guowei, E-mail: dr.sgw@126.com

Received Date: 30 December 2012

摘要

摘要: 目的：探讨肾上皮样血管平滑肌脂肪瘤（EAML）的临床病理特征、诊断、鉴别诊断、治疗方法及预后。方法：通过观察1例肾EAML患者的临床病理学表现与免疫组化标记并复习有关文献，讨论其组织学特征及临床生物学行为。结果：CT平扫呈略高密度实性肿块，边界清楚，病灶内无明显脂肪密度；增强扫描密度相对均匀，实质期强化程度最高，排泄期密度下降较少。镜检示肿瘤细胞弥漫分布，瘤体主要成分为上皮样细胞，细胞异型性明显，大小形状不等，核大且染色明显加深，偶有多核巨细胞，核分裂像明显。免疫组化染色显示瘤细胞HMB45+，SMA+，CK-。结论：病史、体检结合影像学检查能够给我们提供重要的诊断线索，组织病理学特点结合免疫组化标记有助于该疾病的确诊，治疗方法以手术切除为主，对于预后较差的患者应按照肾细胞癌标准长期随访。
- 肾脏 /
- 上皮样血管平滑肌脂肪瘤 /
- 增强CT /
- 肾切除
Abstract: Objective: To investigate the clinicopathological features, diagnosis, differential diagnosis, treatment and prognosis of renal epithelioid angiomyolipoma (EAML).Method: A case of renal EAML was analyzed by clinicopathological examination and immunohistochemistry. The related literature was reviewed and the histologic features of renal EAML and the clinical biologic behavior were discussed.Result: Unenhanced CT showed that slightly hyperdense lump with clear boundary and no fat could be detected. The mass was enhanced obviously in the parenchymal phase and slightly decreased in excretory phase. Pathological examination showed that tumor was mainly composed of epithelioid cells with invasive hyperplasia of atypical pleomorphism, hyperchromatic nuclei with frequent mitosis, multinucleated giant cells. Immunohistochemically, the neoplastic cells were positive for HMB45 and SMA, but negative for CK.Conclusion: Medical history and physical examination combined with iconographic data can provide us important clues to the diagnosis. Pathological characteristics combined with immunohistochemistry are critical in the final diagnosis. Surgical resection should be the first choice. Long-term follow-up plan should be carried out for some patients with poor prognosis according to the renal cell carcinoma standard guidelines.
- kidney /
- epithelioid angiomyolipoma /
- enhanced CT /
- nephrectomy

HTML全文

参考文献(25)

[1]	Eble J N, Sauter G, Epstein J I, et al. World health organization classification of tumors. Pathology and genetics of tumors of the urinary system and male genital organs[M]. Lyon:IARC Press, 2004:65-69.
[2]	Chandrasoma S, Moatamen N, Chang A, et al. Angiomyolipoma of the kidney:expanding disease spectrum demonstrated by 3 cases[J]. Appl Immunohistochem Mol Morphol, 2004, 12(3):277-283.
[3]	Makhlouf H R, Ishak K G, Shekar R, et al. Melanoma markers in angiomyolipoma of the liver and kidney:a comparative study[J]. Arch Pathol Lab Med, 2002, 126(1):49-55.
[4]	Govender D, Sabaratnam R M, Essa A S, et al. Clear cell "sugar" tumor of the breast:another extrapulmonary site and review of the literature[J]. Am J surg Pathol, 2002, 26(5):670-675.
[5]	Park H K, Zhang S, Wong M K, et al. Clinical presentation of epithelioid angiomyolipoma[J]. Int J Urol, 2007, 14(1):21-25.
[6]	Bissler J J, Kingswood J C. Renal angiomyolipomata[J]. Kidney Int, 2004, 66(3):924-934.
[7]	Mai K T, Perkins D G, Collins J P. Epithelioid cell variant of renal angiomyolipoma[J]. Histopathology, 1996, 28(3):277-280.
[8]	Morioka M, Kinugawa K, Funabiki S. Monotypic epithelioid angiomyolipoma of the kidney:a case report[J]. Int J Urol, 2006, 13(9):1240-1242.
[9]	Martignoni G, Pea M, Reghellin D, et al. PEComas:the past, the present and the future[J]. Virchows Arch, 2008, 452(2):119-132.
[10]	Lane B R, Aydin H, Danforth T L, et al. Clinical correlates of renal angiomyolipoma subtypes in 209 patients:classic, fat poor, tuberous sclerosis associated and epithelioid[J]. J Urol, 2008, 180(3):836-843.
[11]	Aydin H, Magi-Galluzzi C, Lane B R, et al. Renal angiomyolipoma:clinicopathologic study of 194 cases with emphasis on the epithelioid histology and tuberous sclerosis association[J]. Am J Surg Pathol, 2009, 33(2):289-297.
[12]	Faraji H, Nguyen B N, Mai K T. Renal epithelioid angiomyolipoma:a study of six cases and a meta-analytic study. Development if criteria for screening the entity with prognostic significance[J]. Histopathology, 2009, 55(5):525-534.
[13]	Nese N, Martignoni G, Fletcher C D, et al. Pure epithelioid PEComas (so-called epithelioid angiomyolipoma) of the kidney:A clinicopathologic study of 41 cases:detailed assessment of morphology and risk stratification[J]. Am J Surg Pathol, 2011, 35(2):161-176.
[14]	Arrabal-Polo M A, Arrabalp-Martin M, Palao-Yago F, et al. Wünderlich syndrome from a malignant epithelioid angiomyolipoma[J].Urol J, 2009, 6(1):50-53.
[15]	Kim J K, Park S Y, Shon J H, et al. Angiomyolipoma with minimal fat:differentiation from renal cell carcinoma at biphasic helical CT[J]. Radiology, 2004, 230(3):677-684.
[16]	Jinzaki M, Tanimoto A, Narimatsu Y, et al. Angiomyolipoma:imaging findings in lesions with minimal fat[J]. Radiology, 1997, 205(2):497-502.
[17]	Hornic J L, Fletcher C D. Sclerosing PEComa:clincopathologic analysis of a distinctive variant with a predilection for the retroperitoneum[J]. Am J Surg Pathol, 2008, 32(4):493-501.
[18]	Agaimy A, Wunsch P H. Perivascular epithelioid cell sarcoma (malignant PEComa) of the ileum[J]. Pathol Res Pract, 2006, 202(1):37-41.
[19]	Sato K, Ueda Y, Tachibana H, et al. Malignant epithelioid angiomyolipoma of the kidney in a patient with tuberous sclerosis:an autopsy case report with p53 gene mutation analysis[J]. Pathol Res Pract, 2008, 204(10):771-777.
[20]	Moudouni S M, Tligui M, Sibony M, et al. Malignant epithelioid renal angiomyolipoma involving the inferior vena cava in a patient with tuberous sclerosis[J]. Urol Int, 2008, 80(1):102-104.[ZK)]
[26]	Bissler J J, McCormack F X, Young L R, et al. Sirolimus for angiomyolipoma in tuberous sclerosis complex or lymphangioleiomyomatosis[J]. N Engl J Med, 2008, 358(2):140-151.
[27]	Davies D M, Johnson S R, Tattersfield A E, et al. Sirolimus therapy in tuberous sclerosis or sporadic lymphangioleiomyomatosis[J]. N Engl J Med, 2008, 358(2):200-203.
[28]	Wolff N, Kabbani W, Bradley T, et al. Sirolimus and temsirolimus for epithelioid angiomyolipoma[J]. J Clin Oncol, 2010, 28(5):e65-e68.
[29]	Martignoni G, Pea M, Rigaud G, et al. Renal angiomyolipoma with epithelioid sarcomatous transformation and metastases:demonstration of the same genetic defects in the primary and metastatic lesions[J]. Am J Surg Pathol, 2000, 24(6):889-894.
[30]	Higa F, Uchihara T, Haranaga S, et al. Malignant epithelioid angiomyolipoma in the kidney and liver of a patient with pulmonary lymphangioleiomyomatosis:lack of response to sirolimus[J]. Inter Med, 2009, 48(20):1821-1825.